Vanguard Investments Australia
BIO icon

Vanguard Investments Australia’s Bio-Rad Laboratories Class A BIO Stock Holding History

Vanguard Investments Australia’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Hold
4,845
– – ﹤0.01% 1085
2026
Q1 		$1.35M Buy
+4,845
New +$1.4M ﹤0.01% 1038

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Investments Australia's BIO Position: Q2 2026 in Review

Vanguard Investments Australia held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 4,845 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1085.

Vanguard Investments Australia first reported a position in BIO in Q1 2026 and has held it in 2 quarters since. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Vanguard Investments Australia held 4,845 shares of Bio-Rad Laboratories Class A worth $1.42M as of Q2 2026.
  • Vanguard Investments Australia left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1085 holding.
  • Vanguard Investments Australia first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and has held it in 2 quarters since.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.